Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Alnylam Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alnylam Pharmaceuticals Inc. May 8, 202594.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Myriad Genetics Inc. | Grant or award | +59,701 | — | — |
| May 20, 2026 | Alnylam Pharmaceuticals Inc. | Grant or award | +671 | — | — |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Option exercise | +18,000 | $100.65 | $1,811,700 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,645 | $457.44 | $752,489 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,888 | $458.86 | $866,328 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,403 | $459.73 | $645,001 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −473 | $460.71 | $217,916 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −2,290 | $461.92 | $1,057,797 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −1,652 | $463.00 | $764,876 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −799 | $464.36 | $371,024 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −222 | $471.25 | $104,618 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −823 | $472.82 | $389,131 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −838 | $474.22 | $397,396 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −951 | $474.85 | $451,582 |
| Sep 9, 2025 | Alnylam Pharmaceuticals Inc. | Open-market sale | −972 | $476.31 | $462,973 |
Questions about Colleen F. Reitan
What boards is Colleen F. Reitan on?
Colleen F. Reitan sits on the boards of Alnylam Pharmaceuticals Inc. and Myriad Genetics Inc.
How long has Colleen F. Reitan served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.